Amgen Inc. (AMGN)
NASDAQ: AMGN · IEX Real-Time Price · USD
277.37
+3.43 (1.25%)
At close: May 1, 2024, 4:00 PM
279.00
+1.63 (0.59%)
After-hours: May 1, 2024, 6:09 PM EDT

Amgen Revenue

In the year 2023, Amgen had annual revenue of $28.19B with 7.09% growth. Revenue in the quarter ending December 31, 2023 was $8.20B with 19.84% year-over-year growth.

Revenue (ttm)
$28.19B
Revenue Growth
+7.09%
P/S Ratio
5.29
Revenue / Employee
$1,055,805
Employees
26,700
Market Cap
148.65B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 202025.42B2.06B8.83%
Dec 31, 201923.36B-385.00M-1.62%
Dec 31, 201823.75B898.00M3.93%
Dec 31, 201722.85B-142.00M-0.62%
Dec 31, 201622.99B1.33B6.14%
Dec 31, 201521.66B1.60B7.97%
Dec 31, 201420.06B1.39B7.43%
Dec 31, 201318.68B1.41B8.17%
Dec 31, 201217.27B1.68B10.80%
Dec 31, 201115.58B529.00M3.51%
Dec 31, 201015.05B411.00M2.81%
Dec 31, 200914.64B-361.00M-2.41%
Dec 31, 200815.00B232.00M1.57%
Dec 31, 200714.77B503.00M3.53%
Dec 31, 200614.27B1.84B14.79%
Dec 31, 200512.43B1.88B17.82%
Dec 31, 200410.55B2.19B26.26%
Dec 31, 20038.36B2.83B51.29%
Dec 31, 20025.52B1.51B37.54%
Dec 31, 20014.02B386.30M10.64%
Dec 31, 20003.63B289.30M8.66%
Dec 31, 19993.34B621.90M22.88%
Dec 31, 19982.72B317.20M13.21%
Dec 31, 19972.40B161.20M7.20%
Dec 31, 19962.24B299.90M15.46%
Dec 31, 19951.94B292.00M17.72%
Dec 31, 19941.65B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Elevance Health 171.75B
Pfizer 58.50B
Sanofi 51.60B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.86B
Abbott Laboratories 40.11B
Danaher 22.52B
Revenue Rankings